Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2023-01-18

FDA Approved: OLMESARTAN MEDOXOMIL — Original Application (Novadoz Pharmaceuticals LLC)

View source ↗

Summary

FDA approved the original application for Olmesartan Medoxomil, a generic version of the hypertension medication, manufactured by Novadoz Pharmaceuticals LLC.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • OLMESARTAN MEDOXOMIL (olmesartan medoxomil)

Snippet

ORIG AP for OLMESARTAN MEDOXOMIL (OLMESARTAN MEDOXOMIL)